Equity Capital Markets

Company · CIK 1628738

Audentes Therapeutics, Inc.

CIK1628738 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressCA
Listedno ticker on SEC record today
First annual or quarterly report2016-09-01

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-219797
ShelfFinal prospectus
 2017-08-082020-01-175
333-224020
ShelfEffective
 2018-03-292018-10-113
333-217225
Registered companyFinal prospectus
 2017-04-102017-04-194
333-208842
IPOFinal prospectus
 2016-01-042016-07-206

Filings

20
FiledFilingRegistrationAccession
2020-01-17EFFECTDeclared effective 333-2226809999999995-20-000116
2020-01-17EFFECTDeclared effective 333-2197979999999995-20-000113
2018-10-11424B5Shelf takedown 333-2240200001193125-18-297649
2018-10-09424B5Shelf takedown 333-2240200001193125-18-295967
2018-03-29S-3ASRShelf registered 333-2240200001193125-18-102103
2018-01-25424B4Final prospectus 333-2197970001193125-18-019705
2018-01-23424B4Final prospectus 333-2197970001193125-18-017360
2017-08-23EFFECTDeclared effective 333-2197979999999995-17-002186
2017-08-08S-3Shelf registered 333-2197970001193125-17-251489
2017-04-19424B4Final prospectus 333-2172250001193125-17-128786
2017-04-18EFFECTDeclared effective 333-2172259999999995-17-000864
2017-04-17S-1/AAmendment 333-2172250001193125-17-125951
2017-04-10S-1Registration filed 333-2172250001193125-17-117272
2016-07-20424B4Final prospectus 333-2088420001193125-16-652387
2016-07-19EFFECTDeclared effective 333-2088429999999995-16-005181
2016-07-11S-1/AAmendment 333-2088420001193125-16-644856
2016-06-16S-1/AAmendment 333-2088420001193125-16-623579
2016-03-09S-1/AAmendment 333-2088420001193125-16-498603
2016-01-04S-1Registration filed 333-2088420001193125-16-419797
2015-11-06DRSDraft made public 377-011980000950123-15-010941

All filings of this company · CSV